A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer.

This paper describes a randomised clinical trial in patients with advanced breast cancer, comparing the regimen 3M, mitomycin C 7-8 mg m-2 (day 1), mitozantrone 7-8 mg m-2 (day 1 and 21), methotrexate 35 mg m-2 (day 1 and 21) given on a 42 day cycle with a standard anthracycline containing regimen,...

Descripción completa

Detalles Bibliográficos
Autores principales: Powles, T. J., Jones, A. L., Judson, I. R., Hardy, J. R., Ashley, S. E.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1991
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977504/
https://www.ncbi.nlm.nih.gov/pubmed/1892775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977504/
https://www.ncbi.nlm.nih.gov/pubmed/1892775

Ejemplares similares